JOSÉ JOAQUÍN
PORTU ZAPIRAIN
Hospital Universitario de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Cruces (11)
2020
-
Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients
AIDS (London, England), Vol. 34, Núm. 10, pp. 1497-1507
2019
-
Diverse large HIV-1 non-subtype B clusters are spreading among men who have sex with men in Spain
Frontiers in Microbiology, Vol. 10, Núm. APR
-
Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients
AIDS, Vol. 33, Núm. 2, pp. 269-278
2018
-
A case-control study of non-AIDS-defining cancers in a prospective cohort of HIV-infected patients
Medicina Clinica, Vol. 150, Núm. 8, pp. 291-296
-
Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients
AIDS, Vol. 32, Núm. 11, pp. 1423-1430
2012
-
Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-for the treatment of chronic hepatitis C in HIV-infected patients: The PERICO trial
Journal of Infectious Diseases, Vol. 206, Núm. 6, pp. 961-968
2011
-
Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/Hepatitis C virus-coinfected patients treated for chronic hepatitis C
Clinical Infectious Diseases, Vol. 53, Núm. 12, pp. 1291-1295
2010
-
Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis C
AIDS Research and Human Retroviruses, Vol. 26, Núm. 4, pp. 419-424
2009
-
Long-term effectiveness and safety outcomes in HIV-1-infected patients after a median time of 6 years on nevirapine
Current HIV Research, Vol. 7, Núm. 5, pp. 526-532
2008
-
Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens
HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313
1999
-
Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy
AIDS, Vol. 13, Núm. 12, pp. 1497-1502